## VTR: Ventas, Inc. - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_20 -0.2% below STRENGTH zone (4.0-10.0%); PEG 1.74 fails VALUE criteria (<1.0); RSI 73 overbought. Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.4% MRS), overbought RSI (73).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($78.25)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Ventas (NYSE: VTR) sells $500M 5.000% senior notes due 2036 for corporate use**
- Source: Stock Titan | 20251204T221235 | Neutral | Relevance: 100%
- Ventas, Inc. (NYSE: VTR), through its subsidiary Ventas Realty, Limited Partnership, has issued $500 million in 5.000% Senior Notes due 2036. These senior unsecured notes are guaranteed by Ventas, Inc., and the proceeds will be used for general corporate purposes, including potential repayment of other debt and related expenses, offering the company financial flexibility. This issuance is part of a routine funding program under an existing shelf registration and base indenture.

**2. KeyBanc Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $85**
- Source: 富途牛牛 | 20251204T120855 | Bullish | Relevance: 100%
- KeyBanc analyst Austin Wurschmidt has maintained a Buy rating on Ventas Inc ($VTR.US$) and increased the target price from $55 to $85. TipRanks data indicates that Wurschmidt has a 53.3% success rate and a 6.2% average return over the past year. This report summarizes the analyst's updated recommendation and target price for Ventas Inc.

**3. Form 424B2 Ventas, Inc.**
- Source: StreetInsider | 20251203T214600 | Somewhat-Bullish | Relevance: 100%
- Ventas Realty, Limited Partnership is offering $500.0 million in 5.000% Senior Notes due 2036, fully and unconditionally guaranteed by Ventas, Inc. The notes will mature on February 15, 2036, with interest payments commencing on August 15, 2026. This prospectus supplement details the terms of the offering, including redemption options, covenants, and risk factors associated with this investment, noting that the notes are a new issue with no established trading market.

**4. Ventas subsidiary prices $500 million in senior notes due 2036 By Investing.com**
- Source: Investing.com Australia | 20251203T091800 | Somewhat-Bullish | Relevance: 100%
- Ventas Realty, Limited Partnership, a subsidiary of Ventas, Inc., has priced a $500 million public offering of 5.000% Senior Notes due 2036. The healthcare REIT plans to use the proceeds for general corporate purposes, including debt repayment. This announcement follows a strong stock performance for Ventas, with a 39.49% year-to-date return, and recent positive third-quarter earnings that exceeded expectations.

**5. Ventas Announces Pricing of Senior Notes Offering**
- Source: Business Wire | 20251203T000724 | Somewhat-Bullish | Relevance: 100%
- Ventas, Inc. announced that its subsidiary, Ventas Realty, Limited Partnership, has priced an underwritten public offering of $500.0 million aggregate principal amount of 5.000% Senior Notes due 2036. The notes were priced at 99.510% of the principal amount and are expected to close on December 4, 2025. Proceeds will be used for general corporate purposes, including potentially repaying other indebtedness.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 4, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Keybanc | $85 | $70 | +21% |
| 2025-11-25 | Wells Fargo | $88 | $80 | +10% |
| 2025-11-13 | Scotiabank | $80 | $74 | +8% |
| 2025-11-11 | Citigroup | $88 | $80 | +10% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Keybanc | main | Overweight |
| 2025-11-25 | Wells Fargo | main | Overweight |
| 2025-11-13 | Scotiabank | main | Sector Perform |
| 2025-11-11 | Citigroup | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 17 ($4.24M) |
| Sells | 13 ($23.19M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 62.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- Vanguard Group Inc: 15.7% (+2.5%)
- JPMORGAN CHASE & CO: 12.7% (+102.6%)
- Blackrock Inc.: 11.1% (+2.6%)
- State Street Corpora: 6.2% (+3.3%)
- FMR, LLC: 5.7% (+12.1%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.4% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $23M sold (13 transactions in 90 days).
3. Overbought RSI (73) with bearish MACD signals exhaustion.

### Catalysts

- Analyst target momentum: 4 raises (avg +12%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 1.74 elevated, pricing in significant growth expectations. Analyst sentiment positive (4 raises, avg +12%). Insider selling cluster ($23.2M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $37.4B |
| Beta | 0.79 |
| 52W Range | $56.68 - $81.89 |
| Short Interest | 4.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.74 |
| Forward P/E | 142.7 |
| Current P/E | 298.6 |
| YoY Growth | 109.3% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from 2.2% to -0.2% (-2.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.2pp (needs >4.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 73, risk of mean reversion. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.22% (CS: 52) | Neutral |
| RSI_14 | 73.0 | Overbought |
| MACD Histogram | -0.17 | Bearish |
| vs SMA20 | 1.021x | Above |
| vs SMA50 | 1.091x | Above |
| vs SMA200 | 1.179x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $80.61
- **Stop Loss:** $78.25 (2.9% risk)
- **Target:** $82.97 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 211
- **Position Value:** $17,008.71
- **Portfolio %:** 17.01%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-11 (Est: $0.09)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.05 | $0.12 | +141.9% |
| 2025Q2 | $0.14 | $0.15 | +10.4% |
| 2025Q1 | $0.07 | $0.10 | +35.8% |
| 2024Q4 | $0.05 | $0.13 | +156.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*